Science Daily: Pharmacology News
SEPTEMBER 10, 2024
When they become fathers, men who have an unhealthy, high-cholesterol diet can cause increased risk of cardiovascular disease, or CVD, in their daughters, a mouse study has found.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- Taking steroids more than doubles a person’s risk of developing type 2 diabetes, a new study warns.Patients taking steroid pills, injections or infusions are 2.6 times more likely to develop diabetes than those not on s.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Science Daily: Pharmacology News
SEPTEMBER 10, 2024
Methane concentrations in Earth's atmosphere increased at record speed over the past five years. At least two-thirds of annual methane emissions now come from human activities, including fossil fuel use, agriculture, and landfills and other waste.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame had few pauses in their breathing while asleep, as well as higher levels of blood oxygen.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily: Pharmacology News
SEPTEMBER 10, 2024
When cars, planes, ships or computers are built from a material that functions as both a battery and a load-bearing structure, the weight and energy consumption are radically reduced. A research group is now presenting an advance in so-called massless energy storage -- a structural battery that could halve the weight of a laptop, make the mobile phone as thin as a credit card or increase the driving range of an electric car by up to 70 percent on a single charge.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
BioPharma Drive: Drug Pricing
SEPTEMBER 10, 2024
A small, early study produced what one analyst called “highly compelling” results that lifted the company’s shares by as much as 15% Tuesday.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- New research uncovers a possible reason why teenaged girls struggled so mightily with their mental health during the pandemic: Scans showed their brains aged far faster than expected during that stressful time, even.
BioPharma Drive: Drug Pricing
SEPTEMBER 10, 2024
The Biosecure Act, which limits contracts with WuXi AppTec, WuXi Biologics and three other companies, still needs Senate support to advance.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- Annoyed that you still have a bit of tummy even though you work out all the time?Exercise actually is helping you develop healthier belly fat tissue, a new study says.That means that even if you don’t obtain six-pack abs.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
BioPharma Drive: Drug Pricing
SEPTEMBER 10, 2024
The partners’ ADC didn’t significantly extend survival in lung cancer patients who were expected to benefit the most from treatment in a Phase 3 trial.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests.Patients who took sulthiame had few pauses in their breathing while asleep, as well as higher levels of blood oxygen.
BioPharma Drive: Drug Pricing
SEPTEMBER 10, 2024
The fund is Bain’s fourth and follows several recent acquisitions of some of its portfolio companies, among them Jnana Therapeutics and EyeBio.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- A flare-up in COPD can be predicted through changes in a person’s voice, a new study claims.Patients’ voices become higher-pitched, more breathy or hoarse when a flare-up is imminent, researchers found.Using those cues, re.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
addgene Blog
SEPTEMBER 10, 2024
Antibody validation is to confirm (or refute) that the antibody is selectively detecting the target-of-interest in your assay and sample-of-interest. The approaches available broadly map onto the five pillars of antibody validation (see: Uhlen et al., 2016 ). In this post, we will describe the approaches that can be used to determine selectivity of an antibody for flow cytometry experiments.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- The latest AirPods from Apple will come with built-in hearing aids, the company announced Monday.Designed as an over-the-counter hearing aid feature for those with mild to moderate hearing loss, users take hearing tests.
Drug Patent Watch
SEPTEMBER 10, 2024
The generic drug market has experienced significant growth over the past few decades, driven by the passage of the Hatch-Waxman Act in 1984 and subsequent legislation. Today, the market is more competitive than ever, with generic drugs accounting for over 90% of all prescriptions in the United States.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- An analysis of where suicides are occurring in the United States shows that, tragically, location matters. People living in poorer areas with fewer resources are significantly more likely to fall victim to suicide versus.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
NIOSH Science Blog: Drugs
SEPTEMBER 10, 2024
Where It Started As the Nanotechnology Research Center (NTRC) marks its 20th anniversary, we reflect on our achievements in the field of nanotoxicology. Within the National Institute for Occupational Safety and Health (NIOSH), one NTRC goal is to understand possible harm from nanomaterials in workplaces. Our work has its origins in earlier research.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- Brain changes that signal Alzheimer's disease even before symptoms appear are linked to an increased vulnerability to financial scams, new research shows.“Assessing financial vulnerability in older adults could help i.
Drug Target Review
SEPTEMBER 10, 2024
The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. To achieve an aggressive timeline from DNA to investigational new drug (IND) application, drug developers have strengthened collaborations with contract development & manufacturing organisations (CDMOs) to expedite drug development.
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- People with type 2 diabetes are nearly twice as likely to develop asthma, a new review has concluded.Type 2 diabetics are 83% more likely to develop asthma, compared to those without diabetes, researchers found.The.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
New Drug Approvals
SEPTEMBER 10, 2024
Zelatriazin, C 18 H 15 F 3 N 4 O 3 , 392.3 g/mol 1929519-13-0 NBI-1065846 or TAK-041 Phase 2 (S)-2-(4-oxobenzo[d][1,2,3]triazin-3(4H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide Zelatriazin ( NBI-1065846 or TAK-041 ) is a small-molecule agonist of GPR139. It was developed for schizophrenia and anhedonia in depression but trials were unsuccessful and its development was discontinued in 2023. [1] [2] [3] [4] [5] [6] [7] SCHEME SYN WO2016081736 [link] Example 2: (S)-2-(4-oxobenzo[d][l,2,3]
Drugs.com
SEPTEMBER 10, 2024
TUESDAY, Sept. 10, 2024 -- Having asthma appears linked to raised odds for miscarriage and troubles with fertility among women, new Danish research shows.“We found that women fulfilling the definition of asthma had a higher rate of fetal loss and a.
New Drug Approvals
SEPTEMBER 10, 2024
Vorasidenib 6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine CAS 1644545-52-7 , C 14 H 13 ClF 6 N 6 , 414.74 FDA APPROVED, 8/6/2024, Voranigo , To treat Grade 2 astrocytoma or oligodendroglioma UNII 789Q85GA8P AG 881 AG-881 AG881 Ingredient UNII CAS InChI Key Vorasidenib citrate X478M962XG 2316810-02-1 YOUTVRFNJAAFNS-DLVAHKFUSA-N Vorasidenib citrate anhydrous W4XG3EQK7B 2316810-00-9 OCEHQNOYRLHJCI-WPRTUUMNSA-N Vorasidenib , sold under the brand name
Perficient: Drug Development
SEPTEMBER 10, 2024
Nowadays, AI is a crucial field with various frameworks like ML.NET that can be used to build amazing applications using pre-built models from cloud providers. It’s important to learn how these services work behind the scenes, how to create custom models, and understand how your application can interact with AI frameworks beyond just cloud providers or the source of the AI services.
Fierce BioTech
SEPTEMBER 10, 2024
Women’s Health: Experts Talk Economics, Education & Equality dwunderlin Tue, 09/10/2024 - 12:32 Wed, 10/16/2024 - 11:00 Resource Type Webinar Dorothy Gemmell Aditi Goenka Promotion Start Wed, 09/18/2024 - 13:45 Duration 60 Minutes While just over 50% of people living in the U.S. identify as women, they have an outsized impact on healthcare decisions and spending, influencing 80% of the roughly $4 trillion healthcare system.
Perficient: Drug Development
SEPTEMBER 10, 2024
The healthcare and life sciences industries are rapidly evolving, fueled by the demand for innovation, efficiency, and patient-centric care. Emerging technologies like AI and cloud platforms are reshaping how healthcare organizations operate. Kristen Quick , Director at Perficient and HLS Industry Lead within the Salesforce practice, brings 15 years of expertise to guide transformative initiatives.
Quanticate
SEPTEMBER 10, 2024
Discover what Health Economics and Outcomes Research (HEOR) is and how it’s applied in programming to analyse healthcare data and improve patient outcomes.
Perficient: Drug Development
SEPTEMBER 10, 2024
Computational complexity studies the efficiency of algorithms. It helps classify the algorithm in terms of time and space to identify the amount of computing resources needed to solve a problem. The Big Ω, and Big θ notations are used to describe the asymptotic behavior of an algorithm as a function of the input size. In computer science, computational complexity theory is fundamental to understanding the limits of how efficiently an algorithm can be computed.
Expert insights. Personalized for you.
310 
Let's personalize your content